XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US
XWELL announced the introduction of the Ceragem V6 Therapeutic Thermal Massager at select XpresSpa locations starting in Q2 2024. This FDA-cleared Class II medical device aims to enhance blood circulation, relieve muscle and joint discomfort, and offer muscle relaxation. The new service will be first launched at Salt Lake City International Airport on May 22, 2024, with subsequent launches at Philadelphia and Orlando airports. XWELL's CEO, Scott Milford, states that this integration supports their strategy to increase revenue and retail traffic cost-effectively. The partnership with Ceragem International is part of XWELL's broader tech-forward initiatives, including IV hydration drip therapies and robotic manicures, solidifying its position in travel wellness.
- Introduction of Ceragem V6 is expected to enhance customer experience and drive retail traffic.
- Ceragem V6 is FDA-cleared as a Class II medical device, ensuring safety and credibility.
- Launches in high-traffic airports like Salt Lake City, Philadelphia, and Orlando can boost visibility and revenue.
- Partnership with Ceragem International leverages their innovative technology.
- Previous tech-forward initiatives indicate a strong commitment to innovative wellness solutions.
- Potential to attract a broader customer base with diversified wellness services.
- Initial deployment to select locations, restricting potential immediate revenue impact.
- Dependency on customer acceptance and usage of new technology for projected revenue growth.
- Financial impact uncertain until broader rollout and customer feedback are evaluated.
- High upfront investment in new technology may affect short-term profitability.
Insights
XWELL's introduction of the Ceragem V6 into its XpresSpa locations is a strategic move aimed at enhancing its service offering and tapping into the growing market for wellness services at airports. The deployment of the Ceragem V6, a touchless massage technology cleared by the FDA as a Class II medical device, positions XWELL as a pioneer in the wellness space, particularly in high-traffic locations such as airports.
From a market perspective, investors should note the following: The global wellness industry is seeing substantial growth driven by increasing consumer awareness and demand for health and wellness services. By integrating advanced therapeutic devices, XWELL is likely to attract a new segment of wellness-conscious travelers, thereby potentially increasing foot traffic and revenue per customer. The availability of varied service times (20, 40 and 60 minutes) could also cater to a broader demographic, from quick-relief seekers to those wanting a more prolonged wellness experience.
Moreover, the launch locations — Salt Lake City International Airport, Philadelphia International Airport and Orlando International Airport — are strategic choices, all of which are major hubs with significant passenger volumes, which may significantly boost XWELL's visibility and customer engagement.
In conclusion, this initiative aligns well with industry trends and consumer behavior, potentially translating into positive financial performance in both short-term and long-term horizons. However, the success of this initiative will ultimately depend on the actual user experience and how effectively XWELL can market and scale this offering.
For retail investors, the financial implications of XWELL’s new initiative should be closely examined. The introduction of the Ceragem V6 is poised to be a cost-effective solution that could enhance revenue streams. The device's FDA Class II clearance allows XWELL to market it with a degree of clinical authority, potentially justifying premium pricing for the massage sessions. This could lead to higher average transaction values at XpresSpa locations.
Additionally, XWELL's focus on integrating autonomous services could result in operational efficiencies. Automation means reduced dependence on human labor, cutting down staffing costs and potentially improving profit margins. With healthcare and wellness technology becoming a lucrative market, these advancements could lead to a higher valuation for XWELL if they capitalize on these trends effectively.
However, investors should remain cautious about the potential capital expenditure involved in deploying these technologies across multiple locations. The initial rollout and subsequent scaling could require significant investment and the return on investment (ROI) will depend on the adoption rate by consumers and the competitive landscape in airport wellness services.
Expanded service offering underscores XWELL’s ongoing focus on delivering cost-effective wellness services that drive top-line growth
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced plans to introduce the Ceragem V6 Therapeutic Thermal Massager in select XpresSpa locations beginning in the second quarter of 2024. The fully autonomous and innovative massage solution is designed to rejuvenate and revolutionize relaxation by providing enhanced blood circulation, muscle and joint discomfort, as well as muscle relaxation.
"We are excited to introduce this cutting-edge massage solution to travelers," commented XWELL Chief Executive Officer, Scott Milford. "This offering reflects our ongoing commitment to integrate innovative wellness experiences within our spas, enabling us to cost effectively increase revenue, drive more retail traffic, while also delivering an efficient experience for our customers.”
In the coming months, XpresSpa will begin offering the Ceragem Therapeutic Thermal Massager, Ceragem V6, premium therapeutic massage technology within multiple XpresSpa locations in the United States. This innovative device combines touchless massage, compression, and heat therapy to provide users with a blissful experience of relaxation and relief. Cleared by the FDA as a Class II medical device, the Ceragem V6 offers various service options of 20, 40, and 60 minutes. The Ceragem V6 is currently set to launch May 22, 2024 in Salt Lake City International Airport (SLC) with launches in Philadelphia International Airport (PHL) and Orlando International Airport (MCO) soon after.
”We are pleased to partner with XpresSpa to bring our innovative Ceragem V6 Therapeutic Thermal Massager to travelers across the United States,” said Brian Yang, CEO of Ceragem International. “This collaboration allows us to offer a state-of-the-art wellness experience to a wider audience, providing them with unparalleled relaxation and wellness benefits. We believe that the integration of the Ceragem V6 at XpresSpa locations will enhance the travel experience of many customers by offering a unique blend of therapeutic touchless massage, compression, and heat therapy.”
These offerings complement a series tech-forward initiatives across the XWELL portfolio, including the recent pilot integration of Revitalize's IV hydration drip therapies in our Miami International Airport (MIA) XpresSpa and the successful introduction of Clockwork MiNiCURE robotic manicures at our Harry Reid International Airport (LAS) XpresSpa. These strategic initiatives demonstrate XWELL's pursuit of cost-effective revenue growth, solidifying its position as a leader in travel wellness.
For more information about these groundbreaking products and XpresSpa, visit www.xpresspa.com.
About XWELL, Inc.
XWELL, Inc. (Nasdaq: XWEL) is a leading global wellness holding company operating multiple brands: XpresSpa®, Treat™, Naples Wax Center®, XpresCheck® and HyperPointe™.
- XpresSpa is a leading retailer of wellness services and related products, with 32 locations in 15 airports globally.
- Naples Wax Center is a group of upscale skin care boutiques, with three locations currently operating.
- XpresCheck is a provider of screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify new SARS-CoV-2 variants of interest and concern as well as other pathogens entering the country from across the world.
- HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.
About Ceragem
Ceragem Inc. is a renowned global home healthcare company dedicated to transforming the future of home healthcare. Specializing in therapeutic massage products and services, Ceragem Inc. aims to enhance the well-being and quality of life for individuals worldwide. By integrating advanced technology and innovative design, Ceragem Inc. provides solutions that bring professional-level therapeutic care directly into the comfort of your home.
Forward-Looking Statements
This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events, including the Company’s current plans and expectations relating to the business and operations and future store openings, including but not limited to, future openings of Naples Wax Center and XpresSpa stores, are based upon information available to XWELL as of the date of this press release, and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.
FAQ
What new service is XWELL introducing at XpresSpa locations?
When will the Ceragem V6 launch at Salt Lake City International Airport?
What benefits does the Ceragem V6 offer?
What other tech-forward initiatives has XWELL recently integrated?
In which airports will the Ceragem V6 be available after the initial launch?
What is the significance of the Ceragem V6 being a Class II medical device?
How does XWELL plan to benefit from introducing the Ceragem V6?
